Expanding Our Mission: Alerje Tackles Opioid Crisis in Military and Veteran Communities, Leveraging Proven AI Tech for Rapid Naloxone Distribution

DETROIT ~ Alerje, Inc. has been selected by AFWERX for a SBIR Phase I focused on developing a Rapid Naloxone Deployment System (RNDS) to address the opioid crisis in the Department of the Air Force (DAF). The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations they fund.

Javier Evelyn, Founder & CEO of Alerje, expressed his enthusiasm for this new venture with the Air Force/AFWERX. "We're deeply committed to leveraging our team's technical 'super powers' and industry experience to address the escalating opioid crisis. Our journey in health tech, especially in emergency medicine, has always had the opioid epidemic on our radar. We're excited to bring our fresh perspective and partnerships to providing much needed aid in this growing crisis. This new venture marks a significant step in our mission to deliver impactful, life-saving technologies to those who need them most."

More on Michimich.com
The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating small business experience through faster proposal-to-award timelines, expanding opportunities for small businesses and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution.

The views expressed are those of Alerje and do not necessarily reflect the official policy or position of the Department of the Air Force, Department of Defense or U.S. government.
Filed Under: Business

Show All News | Report Violation